D. Western Therapeutics Institute (TSE:4576) Net Margin %: 0.00% (As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
51 GF Score
Price 円69.00
GF Value 円64.35
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Net Margin %?

D. Western Therapeutics Institute TSE:4576 51 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 51/100 and a GF Value™ of 円64.35 (Fairly Valued). The stock has 3 warning signs investors should review. Among 946 Biotechnology companies, D. Western Therapeutics Institute ranks worse than 67.76% on this metric.

Net margin is calculated as Net Income divided by its Revenue. D. Western Therapeutics Institute's Net Income for the three months ended in Dec. 2025 was 円0.00 Mil. D. Western Therapeutics Institute's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, D. Western Therapeutics Institute's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for D. Western Therapeutics Institute's Net Margin % or its related term are showing as below:

TSE:4576' s Net Margin % Range Over the Past 10 Years
Min: -615.48   Med: -156.99   Max: 22.95
Current: -368.47


TSE:4576's Net Margin % is ranked worse than
67.76% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs TSE:4576: -368.47

D. Western Therapeutics Institute  (TSE:4576) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


D. Western Therapeutics Institute Net Margin % Related Terms


D. Western Therapeutics Institute Net Margin % Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Net Margin % Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.95 -95.89 -189.65 -273.61 -163.07

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -155.20 -217.96 0.00 -1,130.12

TSE:4576 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, D. Western Therapeutics Institute's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D. Western Therapeutics Institute Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's Net Margin % distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's Net Margin % falls into.


TSE:4576
51GF Score
D. Western Therapeutics Institute Inc TSE:4576
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

D. Western Therapeutics Institute's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-632.087/387.62
=-163.07 %

D. Western Therapeutics Institute's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
D. Western Therapeutics Institute (TSE:4576) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on D. Western Therapeutics Institute and its competitors. According to the industry distribution chart, D. Western Therapeutics Institute ranks #641 out of 946 companies in the Biotechnology industry, placing it in the top 67.8%.
Is D. Western Therapeutics Institute's Net Margin % too high?
D. Western Therapeutics Institute's current Net Margin % is 0.00%. Based on the distribution chart, D. Western Therapeutics Institute ranks #641 out of 946 companies in the Biotechnology industry, which is below the industry midpoint. Overall, D. Western Therapeutics Institute has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, D. Western Therapeutics Institute ranks #641 out of 946 companies for Net Margin %. This places D. Western Therapeutics Institute in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Fairly Valued. The stock's GF Value™ is 円64.35, compared to a current price of 円69.00 — trading 7.2% above its estimated fair value. The current Net Margin % is 0.00%. D. Western Therapeutics Institute's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円69.00 is trading 7.2% above its estimated GF Value™ of 円64.35. GuruFocus considers D. Western Therapeutics Institute to be Fairly Valued.

Key valuation signals for TSE:4576:

  • Net Margin %: 0.00%
  • GF Value™: 円64.35 vs. price of 円69.00 (7.2% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
51GF Score

Get the complete analysis for TSE:4576

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円69.00
Price
円64.35
GF Value